Mauro Galeazzi - Concepedia

Author

Mauro Galeazzi

Also Known As

Carlo Salvarani, Galeazzi Mauro, Galeazzi, Mauro, M Galeazzi, MAURO GALEAZZI, Mauro Galeazzi, Salvatore De Vita, Stefania Gasperini, The Collaborative Group on the Genetics of SLE

256

Publications

13.1K

Citations

H-Index

152

Concepts

All Affiliations

University of Siena University of Bari Aldo Moro University of Florence Università Cattolica del Sacro Cuore University of Padua

About

Mauro Galeazzi is an author at University of Siena specializing in medicine, autoimmune disease, and rheumatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	34	58	4K
2	Public Health	8	8	540
3	Health Sciences	4	4	57
4	Arts	1	1	19
5	Natural Sciences	1	1	23

Mauro Galeazzi

139

Publications

9.8K

Citations

H-Index

Page 1

	Year	Citations
Immunosuppressive therapy in lupus nephritis: The Euro‐Lupus Nephritis Trial, a randomized trial of low‐dose versus high‐dose intravenous cyclophosphamide Frédéric Houssiau, Carlos Vasconcelos, David D’Cruz, Arthritis & Rheumatism	2002	1.1K
Systemic Lupus Erythematosus Ricard Cervera, Munther A. Khamashta, Josep Font, Medicine Sicca SyndromeVasculitisDermatologyPsoriatic ArthritisRheumatoid Disorder	1993	979
Morbidity and Mortality in Systemic Lupus Erythematosus During a 5-Year Period: A Multicenter Prospective Study of 1,000 Patients Ricard Cervera, Munther A. Khamashta, Josep Font, Medicine	1999	430
Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: Lessons from long‐term followup of patients in the Euro‐Lupus Nephritis Trial Frédéric Houssiau, Carlos Vasconcelos, David D’Cruz, Arthritis & Rheumatism	2004	382
miR-223 is overexpressed in T-lymphocytes of patients affected by rheumatoid arthritis Valerio Fulci, Gina Scappucci, Gian Domenico Sebastiani, Human Immunology InflammationRheumatologyRheumatoid DisorderAutoimmune DiseaseRheumatic Diseases	2009	284
Guidance on Noncorticosteroid Systemic Immunomodulatory Therapy in Noninfectious Uveitis Andrew D. Dick, James T. Rosenbaum, Hassan Al-Dhibi, Ophthalmology	2018	244
Obesity and reduction of the response rate to anti–tumor necrosis factor α in rheumatoid arthritis: An approach to a personalized medicine Elisa Gremese, Antonio Carletto, Melissa Padovan, Arthritis Care & Research	2012	203
Biochemical investigation of the effects of human platelet releasates on human articular chondrocytes Adriano Spreafico, Federico Chellini, Bruno Frediani, Journal of Cellular Biochemistry	2009	166
Good clinical response, remission, and predictors of remission in rheumatoid arthritis patients treated with tumor necrosis factor-alpha blockers: the GISEA study. Luana Mancarella, Francesca Bobbio‐Pallavicini, Fulvia Ceccarelli, PubMed	2007	142
Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet’s disease-related uveitis: a multicenter retrospective observational study Claudia Fabiani, Antonio Vitale, Giacomo Emmi, Clinical Rheumatology Clinical ImmunologyInflammationCytokineAutoimmune DiseaseAllergy	2016	132

Page 1